A top Eli Lilly (LLY.N), opens new tab executive said on Monday that more patients are paying the full list price of its obesity drug Zepbound than those who had paid for its predecessor Mounjaro.Patrik Jonsson, President of Lilly Diabetes and Obesity, speaking at a Goldman… Read Full Article (External Site) Dr. David LowemannDr. David […]
Published on June 10, 2024
A closely watched Alzheimer’s drug from Eli Lilly won the backing of federal health advisers on Monday, setting the stage for the treatment’s expected approval for people with mild dementia caused by the brain-robbing disease. Food and Drug Administration advisers voted… Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, Ph.D., is a […]
Published on June 10, 2024
Physicians who staff emergency rooms across the country say a bad situation is getting worse. Patients are experiencing painfully long delays waiting to be admitted to a hospital ─ an issue called ER boarding. According to USA Today, seniors are the most likely and frequent… Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, […]
Published on June 10, 2024